| Treatment Clinical Practice in Bipolar Depression in Spain (NCT00757328) | AstraZeneca | 2008-07-01 |
| Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone (NCT00683657) | AstraZeneca | 2008-07-01 |
| Assessment of the Effect of Food on ABT-143 Bioavailability (NCT00719693) | AstraZeneca | 2008-07-01 |
| A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers (NCT00726427) | AstraZeneca | 2008-07-01 |
| A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis (NCT00713544) | AstraZeneca | 2008-07-01 |
| Determine the Effect of Multiple Doses of AZD7325, CYP Study (NCT00790114) | AstraZeneca | 2008-07-01 |
| Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies (NCT00710515) | AstraZeneca | 2008-07-01 |
| Add-on to Thiazolidinedione (TZD) Failures (NCT00683878) | AstraZeneca | 2008-07-01 |
| Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison (NCT00702676) | AstraZeneca | 2008-07-01 |
| Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan) (NCT00709553) | AstraZeneca | 2008-07-01 |
| Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder (NCT00745966) | AstraZeneca | 2008-07-01 |
| Schizophrenic Patients in Integrated Care (NCT00681629) | AstraZeneca | 2008-07-01 |
| To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects (NCT00738322) | AstraZeneca | 2008-07-01 |
| European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00722267) | AstraZeneca | 2008-07-01 |
| A Study of Tor Kinase Inhibitor in Advanced Tumors (NCT00731263) | AstraZeneca | 2008-07-01 |
| Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin (NCT00723424) | AstraZeneca | 2008-07-01 |
| Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin (NCT00722956) | AstraZeneca | 2008-07-01 |
| Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia (NCT00749970) | AstraZeneca | 2008-07-01 |
| Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00706914) | AstraZeneca | 2008-06-30 |
| Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control (NCT00698932) | AstraZeneca | 2008-06-01 |
| Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours (NCT00710268) | AstraZeneca | 2008-06-01 |
| Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers (NCT00711074) | AstraZeneca | 2008-06-01 |
| Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets. (NCT00713791) | AstraZeneca | 2008-06-01 |
| Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans (NCT00702325) | AstraZeneca | 2008-06-01 |
| National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups (NCT00699959) | AstraZeneca | 2008-06-01 |
| A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00703391) | AstraZeneca | 2008-06-01 |
| Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese (NCT00738959) | AstraZeneca | 2008-06-01 |
| AZD0530 Study 21 - Phase I Study in Patients With Solid Tumours (NCT00704366) | AstraZeneca | 2008-06-01 |
| Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy (NCT00692874) | AstraZeneca | 2008-06-01 |
| Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056 (NCT00700986) | AstraZeneca | 2008-06-01 |
| Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval (NCT00713336) | AstraZeneca | 2008-06-01 |
| An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers (NCT00721448) | AstraZeneca | 2008-06-01 |
| 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease (NCT00680017) | AstraZeneca | 2008-06-01 |
| Formulation and Food Effect Study of AZD1386 in Healthy Volunteers (NCT00714337) | AstraZeneca | 2008-06-01 |
| A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer (NCT00556023) | AstraZeneca | 2008-06-01 |
| Food Effect Study of a Single Dose of ZD4054 (Zibotentan) (NCT00710047) | AstraZeneca | 2008-06-01 |
| Esophageal Hypersensitivity Study in Healthy Volunteers (NCT00711048) | AstraZeneca | 2008-06-01 |
| AZD1386 Japanese Multiple Ascending Dosing Study (NCT00736658) | AstraZeneca | 2008-06-01 |
| A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator. (NCT00720421) | AstraZeneca | 2008-06-01 |
| Quality of Life Analysis of Arimidex Treatment in Postmenopausal Patients With Breast Cancer (NCT00692289) | AstraZeneca | 2008-06-01 |
| National Survey on Dyslipidemic Patients (NCT00701402) | AstraZeneca | 2008-06-01 |
| An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets (NCT00643851) | AstraZeneca | 2008-06-01 |
| Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes (NCT00661362) | AstraZeneca | 2008-06-01 |
| Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment (NCT00663260) | AstraZeneca | 2008-06-01 |
| Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes (NCT00658021) | AstraZeneca | 2008-05-30 |
| Retrospective Brazilian Study of Fulvestrant in Advanced Breast Cancer (NCT00660803) | AstraZeneca | 2008-05-01 |
| AZD2624 Multiple Ascending Dose Study in Japan (NCT00696865) | AstraZeneca | 2008-05-01 |
| CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse. (NCT00714038) | AstraZeneca | 2008-05-01 |
| Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in France (NCT00681837) | AstraZeneca | 2008-05-01 |
| Phase IIA Study in Patients With Schizophrenia (NCT00686998) | AstraZeneca | 2008-05-01 |
| Uric Acid Study in Healthy Male Volunteers (NCT00738842) | AstraZeneca | 2008-05-01 |
| Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia (NCT00683618) | AstraZeneca | 2008-05-01 |
| An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) (NCT00683462) | AstraZeneca | 2008-05-01 |
| A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders (NCT00642811) | AstraZeneca | 2008-05-01 |
| Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients (NCT00699725) | AstraZeneca | 2008-05-01 |
| Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. (NCT00521365) | AstraZeneca | 2008-05-01 |
| CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach) (NCT00681122) | AstraZeneca | 2008-05-01 |
| Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (NCT00690482) | AstraZeneca | 2008-05-01 |
| Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (NCT00703534) | AstraZeneca | 2008-05-01 |
| A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer (NCT00661609) | AstraZeneca | 2008-05-01 |
| Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium (NCT00681395) | AstraZeneca | 2008-05-01 |
| Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke (NCT00681707) | AstraZeneca | 2008-05-01 |
| Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects (NCT00562250) | AstraZeneca | 2008-05-01 |
| Analysis of Antihypertensive Treatment Efficacy (NCT00767247) | AstraZeneca | 2008-05-01 |
| A Diabetes Study to Treat A Population Previously Not at Target (NCT00747149) | AstraZeneca | 2008-05-01 |
| Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia (NCT00687492) | AstraZeneca | 2008-05-01 |
| Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066 (NCT00686504) | AstraZeneca | 2008-04-01 |
| To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305 (NCT00689247) | AstraZeneca | 2008-04-01 |
| Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients (NCT00660114) | AstraZeneca | 2008-04-01 |
| Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects (NCT00672399) | AstraZeneca | 2008-04-01 |
| Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males (NCT00676117) | AstraZeneca | 2008-04-01 |
| Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin (NCT00673231) | AstraZeneca | 2008-04-01 |
| Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US (NCT00660660) | AstraZeneca | 2008-04-01 |
| Study to Examine Safety, Tolerability, and Effect on Body Weight of Metreleptin Administered in Conjunction With Pramlintide in Obese and Overweight Subjects (NCT00673387) | AstraZeneca | 2008-04-01 |
| Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386 (NCT00672646) | AstraZeneca | 2008-04-01 |
| Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia (NCT00669903) | AstraZeneca | 2008-04-01 |
| Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers (NCT00691353) | AstraZeneca | 2008-04-01 |
| Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination (NCT00688428) | AstraZeneca | 2008-04-01 |
| Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma (NCT00667992) | AstraZeneca | 2008-04-01 |
| Study to Compare Different Formulations of AZD3355 (NCT00688402) | AstraZeneca | 2008-04-01 |
| AZD6140 Oral Contraceptive Interaction Study (NCT00685906) | AstraZeneca | 2008-04-01 |
| Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics (NCT00689325) | AstraZeneca | 2008-04-01 |
| 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D) (NCT00666458) | AstraZeneca | 2008-04-01 |
| CARE - Quality Improvement in Cardiovascular Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse. (NCT00713960) | AstraZeneca | 2008-04-01 |
| Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice (NCT00782314) | AstraZeneca | 2008-04-01 |
| Retrospective Survey for Patients With Hypertension and Diabetes Mellitus (NCT00681278) | AstraZeneca | 2008-04-01 |
| Quetiapine Fumarate (Seroquel) as Mono-Therapy or Adjunct to Lithium in the Treatment of Patients With Acute Mania in Bipolar Disorder (NCT00672490) | AstraZeneca | 2008-04-01 |
| National Survey on Hypertension in General Practitioner (GP) Consultation (NCT00695656) | AstraZeneca | 2008-04-01 |
| Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients (NCT00680745) | AstraZeneca | 2008-04-01 |
| Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006 (NCT00695357) | AstraZeneca | 2008-04-01 |
| Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) (NCT00641056) | AstraZeneca | 2008-04-01 |
| AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer (NCT00610714) | AstraZeneca | 2008-04-01 |
| Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time. (NCT00717119) | AstraZeneca | 2008-04-01 |
| Pharmacokinetics, Safety & Tolerability of ZD4054 (Zibotentan) in Subjects With Normal, Mild, Moderate and Severe Hepatic Impairment (NCT00672581) | AstraZeneca | 2008-04-01 |
| Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand (NCT00684151) | AstraZeneca | 2008-04-01 |
| AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers (NCT00690404) | AstraZeneca | 2008-04-01 |
| Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours (NCT00633269) | AstraZeneca | 2008-04-01 |
| Explorative Study of AZD1305 in Atrial Fibrillation Patients (NCT00643448) | AstraZeneca | 2008-03-01 |
| OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment. (NCT00681850) | AstraZeneca | 2008-03-01 |
| Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects (NCT00689559) | AstraZeneca | 2008-03-01 |